A team of researchers at VCU Massey Comprehensive Cancer Center has identified a new pathway through which mutations in the tumor suppressor p53 gene—found very frequently in human tumors—hijack DNA ...

A new study shows that ultramarathons damage and replenish red blood cells in ways that could help treat cancer patients.

Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Apitegromab improved motor function in SMA patients in a Phase 3 trial analysis, with stronger benefits seen in those treated earlier.

Restoring the gut microbiota through fecal microbiota transplantation reversed these effects. The treatment replenished CX3CR1-positive NK cells, reduced lung damage, and improved survival. Targeted ...

Pancreatic cancer cells can regulate their tolerance to chemotherapy depending on what they detect in their surroundings, according to NYU Langone researchers. With that, it’s unlikely that a single ...

Lingering inflammation from viruses like COVID-19 or HIV can take a lasting toll on the brain. New research shows exactly how specific immune system imbalances lead to memory lapses and slowed ...

Today, scientists estimate that between seven and ten million people worldwide live with Parkinson’s disease. Even though the disease has been studied for many decades, doctors still do not fully ...

Researchers have identified a potential treatment strategy for Rett syndrome via alternative splicing modulation of the MECP2 gene.

Research led by scientists at Washington State University has revealed insights on how plants form a microscopic landscape of proteins crucial to photosynthesis, the basis of Earth's food and energy ...

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...